The ‘Father of Modern Food and Drug Law,’ Peter Hutt, Joins EVŌQ Nano Board of Directors
Hutt Brings Decades of Regulatory Insight to Help Advance Nanoparticle Technology Platform SALT LAKE CITY, Utah (April 9, 2025) — EVŌQ Nano, a nanoscience company that engineers novel nanoparticles for the life, material, and textile science industries, today announced the appointment of Peter Barton Hutt, former FDA Chief Counsel, to its board of directors. Widely […]
EVŌQ Nano Secures Strategic Investment From Global Business Leader & Philanthropist Tony Robbins to Advance Next-Generation Antimicrobial Nanoparticle Technology
SALT LAKE CITY, Jan. 30, 2025 — EVŌQ Nano, a nanoscience company that engineers novel nanoparticles for the life, material, and textile science industries, today announced a strategic investment from Tony Robbins, the renowned business and life strategist, #1 New York Times bestselling author, entrepreneur, and philanthropist. The partnership will support the continued development of EVŌQ Nano’s groundbreaking antimicrobial nanoparticle platform. […]
EVŌQ Nano Expands Antimicrobial Medical Device Platform, Demonstrates Efficacy Across Multiple Device Applications
Four Integration Methods Aim to Combat Healthcare-Associated Infections & Improve Device Performance SALT LAKE CITY, Utah (Nov. 19, 2024)–EVŌQ Nano, a nanoscience company that engineers novel nanoparticles for the life, material, and textile science industries, today announced its antimicrobial medical device platform is demonstrating success in a range of applications aimed at combating healthcare-associated infections […]
EVŌQ Nano Advances Research on EVQ-218 Nanoparticle as United Nations Convenes for High-Level Meeting on Antimicrobial Resistance
New Infographic Illustrates EVQ -218’s Novel Approach to Combatting the World’s Worst Superbugs Without Triggering Antimicrobial Resistance SALT LAKE CITY, Utah, (Sept. 26, 2024) — As the United Nations (UN) prepares to address the escalating threat of antimicrobial resistance, EVŌQ Nano is helping raise awareness through an educational infographic depicting a common trigger of antimicrobial […]
EVŌQ Nano’s EVQ-218 Nanoparticle Addresses Critical Gap in Fight Against Antibiotic-Resistant Bacteria
Non-Ionic EVQ-218 Demonstrates Success in Combating Leading Pathogens Without Triggering Antimicrobial Resistance (AMR) SALT LAKE CITY, Utah, (July 16, 2024) — The World Health Organization (WHO) last month called for urgent innovation in antibacterial agents to combat serious infections and replace those becoming ineffective due to widespread use. EVŌQ Nano’s groundbreaking nanoparticle, EVQ-218, is intended […]
EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections
Major Milestone for EVŌQ Nano’s Biotech Arm Targeting Antibiotic-Resistant Bacterial Infections Linked to Cystic Fibrosis and Other Lung Diseases SALT LAKE CITY, Utah, (May 15, 2024) — EVŌQ Bio, a wholly-owned subsidiary of EVŌQ Nano, today announced the successful completion of a Pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) […]
Journal of the American Chemical Society Differentiates EVŌQ Nano’s EVQ-218 Nanoparticle as a New Form of Silver;Holds Promise for Widespread Medical Applications
SALT LAKE CITY, Utah, (April 16, 2024) — EVŌQ Nano, a nanoscience company that engineers novel nanoparticles for the life, materials, and textile science industries, today announced that the American Chemical Society journal, ACS Omega, published a peer-reviewed study characterizing and differentiating the company’s lead asset, EVQ-218, as a new form of silver nanoparticle (AgNP). […]
EVŌQ Nano Announces That Its Antimicrobial Medical Device Platform Demonstrates Success Against the Leading Cause of Healthcare-Associated Infections
Novel Nanoparticle Platform Shows Efficacy Against Antimicrobial Resistance; Potential to Disrupt the $29 Billion Catheter Market